Abstract: There is provided a composite oil seal having an electric corrosion prevention function, which is mounted on a shaft in a motor housing to prevent leakage of oil in the motor housing. The composite oil seal includes a seal main body, which is formed of an elastic material and has an outer circumferential surface formed to be in tight contact with an inner circumferential surface of the motor housing and at least one lip protruding inwards so as to be in contact with an outer circumferential surface of the shaft, and an electrical path fabric, which is formed by weaving metallic yarns and is mounted to the seal main body to electrically connect the shaft to the motor housing so that current induced in the shaft flows to the motor housing.

Abstract: The present invention relates to a flame-retardant nonwoven fabric for a mattress, and a flame-retardant nonwoven fabric for mattresses comprising flame-retardant rayon (FR-Rayon) staple fibers of 20 to 50% by weight; modacrylic staple fibers of 30 to 60% by weight; polyimide (PI) staple fibers of 10 to 30% by weight; and low melting polyester (LM PET) staple fibers of 5 to 20% by weight provides enhanced flame retarding and mechanical properties.

Abstract: Provided is an adhesive for collecting a human body-derived sample from a porous surface of an adherend for DNA type analysis, wherein the adhesive contains a polyurethane aqueous dispersion as a main ingredient.

Abstract: Proposed is an indoor quarantine system using an individual mask. The indoor quarantine system may include: an indoor headcount checking device including a headcount checking unit configured to check the number of persons who stay in an indoor space and a headcount providing unit configured to provide headcount information checked by the headcount checking unit to mobile terminals of indoor users; and a disinfection mask worn on an indoor user and activating a disinfection function in accordance with a disinfection command based on the indoor headcount information received from the mobile terminal of the indoor user to disinfect harmful substances around the indoor user.

Abstract: Disclosed is an antibody for cancer treatment conjugated with a tumor environment-sensitive cleavable polyethylene glycol, wherein the use of the antibody for cancer treatment can suppress side effects of the antibody while maintaining therapeutic effects thereof.

Abstract: Disclosed are a method and apparatus for reusing wastewater. The method for reusing wastewater disclosed herein includes: generating a mixed wastewater by mixing multiple types of wastewater (S20); performing a first purification by passing the mixed wastewater through a flocculation-sedimentation unit (S40); performing a second purification by passing an effluent of the flocculation-sedimentation unit through a membrane bioreactor (MBR) (S60); performing a third purification by passing an effluent of the MBR through a reverse-osmosis membrane unit (S80); and reusing an effluent of the reverse-osmosis membrane unit as cooling water or industrial water (S100).

Abstract: A vehicle height control apparatus includes an information acquisition device that acquires pressure data on a pressure inside an air tank storing compressed air and obstacle data on an obstacle in front of a vehicle, and a controller that calculates a target vehicle height based on the obstacle data, calculates a required distance required to reach the target vehicle height based on the pressure of the compressed air inside the air tank, and determines a vehicle height control timing, resolving a problem that the vehicle height is unnecessarily quickly controlled compared to the position of the obstacle, or is controlled after the vehicle passes through the obstacle to reduce the ride comfort.

Abstract: Disclosed are a method and apparatus for reusing wastewater. The method for reusing wastewater disclosed herein includes: generating a mixed wastewater by mixing multiple types of wastewater (S20); performing a first purification by passing the mixed wastewater through a flocculation-sedimentation unit (S40); performing a second purification by passing an effluent of the flocculation-sedimentation unit through a membrane bioreactor (MBR) (S60); performing a third purification by passing an effluent of the MBR through a reverse-osmosis membrane unit (S80); and reusing an effluent of the reverse-osmosis membrane unit as cooling water or industrial water (S100).

Abstract: Power semiconductor devices comprise a gate pad, a plurality of gate fingers, and a first gate resistor and a first switch that are coupled between the gate pad and the gate fingers.

Abstract: A stacked semiconductor device includes at least one upper chip including a plurality of channels each including first and second pseudo-channels; and a plurality of transfer control circuits respectively corresponding to the channels and each configured to output channel commands according to a channel designation signal designating one of the first and second pseudo-channels and a location information signal indicating a location of a corresponding channel of the channels, and transmit first and second data words between the corresponding channel and a lower chip according to the channel commands.

Abstract: A semiconductor device includes a semiconductor layer structure comprising a source/drain region, a gate dielectric layer on the semiconductor layer structure, and a gate electrode on the gate dielectric layer. The source/drain region comprises a first portion comprising a first dopant concentration and a second portion comprising a second dopant concentration. The second portion is closer to a center of the gate electrode than the first portion.

Abstract: The present disclosure relates to a pharmaceutical composition for preventing or treating a brain disease, comprising a stem cell-derived exosome surface-modified with a compound capable of binding to dopamine receptors or L-amino acid transporters as an active ingredient. The stem cell-derived exosome according to the present disclosure selectively binds to dopamine receptors (D2) overexpressed as autoreceptors in dopaminergic neurons in the substantia nigra through surface modification. Thereby, local accumulation in dopaminergic neurons is possible. In addition, it was identified that the stem cell-derived exosome exhibited an excellent neuron protective effect and neuron death inhibitory effect. Accordingly, the surface-modified stem cell-derived exosome according to the present disclosure is expected to be usefully used as a composition for preventing or treating a brain disease including Parkinson's disease and Alzheimer's disease.

Abstract: The present disclosure relates to a composition and a kit for colonization of external probiotics in the gut through bioorthogonal click chemistry. The composition or kit for colonization of external probiotics in the gut according to the present disclosure has the effects of overcoming colonization resistance, which is the limitation of existing external probiotics caused by physical discharge and indigenous bacteria, by linking surface-modified external probiotics to the intestinal mucosa into which a bioorthogonal functional group has been introduced, and beneficially changing the intestinal environment by long-term colonization of various external probiotics, such as lactic acid bacteria, bifidobacteria, and yeast. Accordingly, the present disclosure is expected to be effectively used for the development of various medicines and functional foods using probiotics.

Abstract: Disclosed herein is a reactor including a reactor vessel and a containment vessel configured to surround the reactor vessel. The containment vessel includes a thermal radiation shield disposed on an inner wall, and a gap between the reactor vessel and the containment vessel is in an atmospheric pressure and air atmosphere state.

Abstract: The present invention relates to a peptide for cancer immunotherapy that disrupts tumor-derived vesicles and a use thereof. The peptide according to the present invention has an ?-helical structure, inhibits T-cell functional impairment caused by tumor-derived vesicles and controls the formation of a tumor microenvironment as an immunosuppressive environment by disrupting the tumor-derived vesicles, and has effects of not only enhancing cancer immunotherapy activity but also inhibiting the metastasis of cancer cells through co-administration with an immune checkpoint inhibitor. Additionally, when the peptide is modified with PEG through a pH-sensitive linker, it has effects of increasing the stability of the peptide in vivo, and disrupting tumor-derived vesicles under the pH condition of the tumor microenvironment.

Abstract: According to an embodiment, a system includes at least one change detecting device that includes a map information storage unit receiving a high-definition map including a property of each road facility object and spatial coordinates of a feature point from a map updating server and storing the received high-definition map, an object coordinates obtaining unit recognizing at least one road facility object from the road image and obtaining a property of the recognized object and spatial coordinates of a feature point. and a changed object detecting unit comparing the property of the recognized object and the spatial coordinates of the feature point with the high-definition map and, if a change object is detected, transmitting object change information including a property and feature point spatial coordinates of the change object to the map updating server.

Abstract: The present invention relates to an antibody-drug conjugate comprising an exosome secretion inhibitor conjugated to an antibody for inhibiting immune checkpoints, and the use thereof for treating cancer. An antibody-drug conjugate according to the present invention is maintained, in normal tissue, in a form in which a drug is conjugated to an antibody, and releases the drug upon reaching a cancer microenvironment, thereby inhibiting the secretion of cancer exosomes that cause an immunosuppressive mechanism. Thus the antibody-drug conjugate exhibits high therapeutic efficacy and can remarkably increase the objective response rate to an immune checkpoint inhibitor.

Abstract: Systems for creating electrodes for polymer electrolyte membrane fuel cells include an XY stage having a heated vacuum table physically coupled to the XY stage. The vacuum table has a working face with a plurality of channels formed therein to communicate vacuum pressure from a port coupled to a vacuum source to the channels. A sheet of perforated heat-conductive material has staggered holes configured to evenly distribute the vacuum pressure from the channels through the perforated sheet. A heat-conductive wire mesh is placed over the perforated sheet, and has openings smaller than the staggered holes such that a membrane material placed on the wire mesh is not deformed by the vacuum pressure. A nanopipette or micropipette coupled to a pump is configured to deposit electrode ink onto an exposed surface of the membrane material as the controller device causes the XY stage to move the vacuum table to control deposition of the electrode ink onto the surface of the membrane material.

Abstract: An apparatus for estimating vehicle weight using a vehicle height adjusting device is provided. The apparatus includes a vehicle height adjusting device that raises or lowers four positions of front left (FL) and right (FR) sides and rear left (RL) and right (RR) sides of a vehicle body, respectively. A vehicle height controller operates the vehicle height adjusting device to raise or lower the FL and FR sides and the RL and RR sides of the vehicle body. A weight estimating unit measures time required for raising or lowering the vehicle body or operating speed of the vehicle body and calculates an expected vehicle weight value by comparing the time required or the operating speed with a preset reference data.

Abstract: Power semiconductor devices comprise a gate pad, a plurality of gate fingers, and a first gate resistor and a first switch that are coupled between the gate pad and the gate fingers.